Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Blaiss MS, Tilles S, Petroni D, et al. Current management and use of oral immunotherapy in the United States for patients with peanut allergy. Allergy Asthma Proc. 2019;40(4):214–20.
2. Chan ES, Dinakar C, Gonzales-Reyes E, et al. Unmet needs of children with peanut allergy: aligning the risks and the evidence. Ann Allergy Asthma Immunol. 2020;124(5):479–86.
3. Blackman AC, Anagnostou A. Identification of goals and barriers to treatment from 92 consecutive consultations with families considering peanut oral immunotherapy. Ther Adv Vaccines Immunother. 2019;7:1–11.
4. Tanno LK, Clark E, Mamodaly M, et al. Food-induced anaphylaxis morbidity: emergency department and hospitalization data support preventive strategies. Pediatr Allergy Immunol. 2021. https://doi.org/10.1111/pai.13578.
5. Nowak-Wegrzyn A, Hass SL, Donelson SM, et al. The peanut allergy burden study: impact on the quality of life of patients and caregivers. World Allergy Organ J. 2021;14(2):100512.